| Completed | 3 | 1412 | RoW | Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA | Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital | Acute Ischemic Stroke | 06/23 | 06/23 | | |
NCT03640884: Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study |
|
|
| Recruiting | N/A | 30000 | RoW | Xueshuantong-Injection, Chenzhong | Zhong Wang | Adverse Drug Event, Adverse Drug Reactions, Anaphylactic Reaction, Severe Adverse Reactions | 12/21 | 06/22 | | |
